Avitas Wealth Management LLC Bio N Tech Se Transaction History

Avitas Wealth Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$126.25 - $231.85 $407,913 - $749,107	-3,231 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$216.64 - $362.52 $27,946 - $46,765	129 Added 4.16%	3,231 $833,000
Q3 2021 Oct 28, 2021	SELL	$205.93 - $447.23 $245,262 - $532,650	-1,191 Reduced 27.74%	3,102 $847,000
Q2 2021 Jul 12, 2021	SELL	$113.32 - $241.49 $323,641 - $689,695	-2,856 Reduced 39.95%	4,293 $961,000
Q1 2021 May 13, 2021	SELL	$85.73 - $119.5 $537,698 - $749,504	-6,272 Reduced 46.73%	7,149 $781,000
Q4 2020 Feb 26, 2021	SELL	$72.71 - $129.54 $75,691 - $134,851	-1,041 Reduced 7.2%	13,421 $1.09 Million
Q3 2020 Oct 06, 2020	BUY	$57.81 - $104.17 $34,512 - $62,189	597 Added 4.31%	14,462 $1 Million
Q2 2020 Jul 30, 2020	SELL	$38.58 - $66.74 $755,820 - $1.31 Million	-19,591 Reduced 58.56%	13,865 $925,000
Q1 2020 May 13, 2020	BUY	$28.55 - $92.0 $955,168 - $3.08 Million	33,456 New	33,456 $1.95 Million

328

40.6M

845K

1.23M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Avitas Wealth Management LLC with notifications on news.